Immunology and allergy

Dr Jessica Tattersall
Clinical Articles iconClinical Articles

Dr Jessica Tattersall discusses the importance of history in order to differentiate between the two and to maximise improvement.

Dr Christopher Worsnop
Videos iconVideos

How to approach patients who still have asthma symptoms despite treatment. It is not an uncommon scenario. The asthma patient presents, still complaining of shortness of breath, wheeze or cough despite having been prescribed the textbook asthma treatments.

Dr Jessica Tattersall
Videos iconVideos

Diagnosing and optimally treating allergic rhinitis can make a significant difference to a sufferer's life. Chronic allergic rhinitis is a common condition that can dramatically affect a person's quality of life.

Dr Linda Calabresi
Clinical Articles iconClinical Articles

The arrival of a new adrenaline autoinjector on the PBS has a significant proportion of Australian GPs concerned about possible confusion and mistakes being made when using the devices to treat anaphylaxis

Maria Said AM
Podcasts iconPodcasts
Expert/s: Maria Said AM
Dr Wendy Freeman
Podcasts iconPodcasts

Refer all suspected food allergies to an allergy specialist, err on the side of caution

Dr Jeremy Rajanayagam
Podcasts iconPodcasts

How to evaluate feed tolerance and when to be clinically concerned

Clinical A/Prof Sheryl Van Nunen
Podcasts iconPodcasts

Mammalian meat allergy is the most common reason patients carry an Epipen in the Northern Beaches of Sydney

Dr Brynn Wainstein
Podcasts iconPodcasts

Dr Wainstein will cover the definition, clinical presentation, diagnosis and management of anaphylaxis. The common causes and epidemiology of anaphylaxis and anaphylaxis related fatalities will be discussed.

Dr Linda Calabresi
Clinical Articles iconClinical Articles

According to Allergist and Medical Rhinologist, Dr Jessica Tattersall, up to 80% of asthmatic children will also have allergic rhinitis.

Dr Linda Calabresi
Clinical Articles iconClinical Articles

We all know that the previous avoidance strategy to prevent young children developing food allergies has been turned on its head. But out there in the real world, many new parents remain very nervous about feeding their six-month-old cooked egg or letting them taste peanut butter. As much as we would like to think a word of reassurance from their trusted GP is all that is needed, such reassurance is likely to carry much more weight if it is accompanied by a written resource from a reputable source. Enter the Prevent Allergies website. Among many other resources available on the site, there is a very succinct, definitive, printable brochure - entitled ‘Nip Allergies in the Bub’ - that clearly outlines the latest evidence-based information about what parents should be feeding their child and when with regard to lowering their risk of food allergies.

Dr Linda Calabresi
Clinical Articles iconClinical Articles

It’s only been around a few years, but this little bit of technology has already received world wide acclaim for its ability to improve the safety of vaccines in the real-world setting. In simple terms, Smartvax is a program practices install into their software system that sends an SMS directly to patients three days after they receive a vaccination. Patients are asked if they experienced an adverse reaction to the vaccine. A straightforward Yes (Y) or No (N) is all that is required. A No reply ends the conversation, but a Yes will trigger a brief questionnaire that examines the nature of the adverse reaction. If the reaction resulted in the need to seek medical attention this is then flagged in the GP’s software inbox as well as with the local health authority. In practical terms this means adverse reactions are tracked in real time and act as an early warning signal that something could be amiss with a vaccine. Smartvax was developed by Perth GP, Dr Alan Leeb and Ian Peters, following a spate of serious and unexpected adverse reactions among young children who received one brand of flu vaccine back in 2010. It was apparent that a better, more time-sensitive system of monitoring side effects to vaccines was needed to ensure the safety of patients. With the widespread use of mobile phones, the day three post vax text has proven a very effective means of tracking reactions, with a high level of acceptance by patients. In a study from one NSW general practice, the response rate to the SMS  text was 85% post-childhood vaccination, and even in the over 65 year age range the response rate was 74%. Smartvax has now been adopted by more than 280 practices around Australia. The technology can also be used as a reminder system to prompt patients when their next vaccine is due. This is such a clever idea and as general practice becomes more and more tech savvy one can envisage a day when Smartvax is a basic requirement for all clinics that provide vaccinations.   >> Access the resource here